An effective and well-tolerated strategy in recurrent and/or metastatic head and neck cancer: successive lines of active chemotherapeutic agents

類似資料

• Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients
  著者:: Fayette, Jérôme, 等
  出版事項: (2016)
• Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma
  著者:: Fayette, Jérôme, 等
  出版事項: (2015)
• Curative treatment can be an option for patients with metastatic squamous cell cancer of the head and neck
  著者:: Guenne, Clémence, 等
  出版事項: (2014)
• Carboplatin in combination with weekly Paclitaxel as first-line therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma unfit to EXTREME schedule
  著者:: Pêtre, Adeline, 等
  出版事項: (2018)
• Hyperprogression and impact of tumor growth kinetics after PD1/PDL1 inhibition in head and neck squamous cell carcinoma
  著者:: Karabajakian, Andy, 等
  出版事項: (2020)